CAS: 23583-21-3; Ethyl 3-(Benzylamino)Propanoate

上下游产品

CAS号100-46-9 苄胺 | CAS号140-88-5 丙烯酸乙酯 | CAS号539-74-2 3-溴丙酸乙酯 | CAS号292638-85-8 丙烯酸甲酯 | CAS号623-71-2 3-氯丙酸乙酯 | CAS号1071-46-1 丙二酸单乙酯 | CAS号2547-66-2 1,3,5-三苄基六氢-S-三嗪 | CAS号6343-54-0 N-苯甲基甲酰胺 | CAS号36320-66-8 ethyl 3-thi°Cya... | CAS号64-17-5 乙醇 | CAS号1067914-81-1 1-苄基-3,3-二氟哌啶-4,4-二醇 | CAS号109162-29-0 1-苄基六氢-4H-氮杂烷-4-醇 | CAS号4450-98-0 EBPC | CAS号19341-60-7 1-benzyl-2-sulf... | CAS号26735-10-4 4-(benzylamino)... | CAS号5291-77-0 N-苄基吡咯烷酮 | CAS号1208-75-9 1-苄基六氢氮杂卓-4-酮 | CAS号1208-76-0 1-苄基-4-氧代氮杂烷盐酸盐 | CAS号70571-31-2 1-苄基哌啶-2,4-二酮 | CAS号716-99-4 2,4(1H,3H)-Pyri...

📜在 Sodium Tetrahydroborate,盐酸体系中,用 乙醇 用作溶剂,化学反应生成3-(苄基氨基)丙酸乙酯
参考文献:Wrinkle-Improving Agent
标题:Wrinkle-Improving Agent
摘要:该发明提供了一种新型的改善皱纹的剂,具有改善皱纹的效果,即使应用于皮肤也不会带来安全或疼痛问题,并且包含一种非常安全的物质作为活性成分.发现n-苯甲酰-β-丙氨酸,其他特定的β-丙氨酸衍生物及其盐具有改善皱纹的效果,因此开发了一种改善皱纹的剂,其活性成分包含从这些特定的β-丙氨酸衍生物及其盐组成的群体中选择的一种,两种或更多种化合物.

专利信息

专利号:CN-114369052-B
优先权日:2021-12-21
标题 :A kind of synthesis method of 3-aminopyrrolidine dihydrochloride

专利号:US-4604397-A
优先权日:1984-05-10
标题:Certain benzo-(pyrano and thiopyrano)-pyridines, useful as CNS agents
发明人：HUTCHISON ALAN J
权利人:CIBA GEIGY CORP
摘要:Disclosed are the compounds of formula I ##STR1## wherein X represents oxygen or sulfur; ring A is unsubstituted or substituted by one to three identical or different substituents selected from hydroxy, hydroxy-lower alkyl, etherified hydroxy, etherified hydroxy-lower alkyl, acyloxy, acyloxy-lower alkyl, halogen, lower alkyl, trifluoromethyl, amino, mono- and di-lower alkylamino and acylamino; or ring A is substituted by one lower alkylenedioxy; R represents hydrogen, lower alkyl or aryl-lower alkyl; R 1 represents hydrogen, lower alkyl, lower alkylthio-lower alkyl, amino, acylamino, (amino, mono- or di-lower alkylamino)-lower alkyl, carboxy, lower alkoxycarbonyl, carbamoyl or mono- or di-lower alkylcarbamoyl; R 2 to R 5 represent hydrogen or lower alkyl; the dehydro derivatives thereof with a double bond at the 1,2-position, or at the 1,10b-position in which case R 5 is absent; or a pharmaceutically acceptable salt thereof; methods for their synthesis; pharmaceutical compositions thereof; and use thereof as psychactive agents for the treatment of central nervous system disorders.